Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy
Recruiting
Phase 1
Interventional Study
Hypoxic Ischemic Encephalopathy of Newborn
At a Glance
- Age
- 1 Day – 30 Days
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 200 (estimated)
- Sponsor
- Armed Forces Hospital, Pakistan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Hypoxic ischemic encephalopathy is an acute or subacute brain injury, due to asphyxia in neonates, leading to mortality and long-term morbidity. Its prevalence varies across regions, with developed countries reporting rates of 1.5 per 1000 live births, while developing nations experience a wider range from 2.3 to 26.5 per 1000 live births.
Infants afflicted with moderate HIE face a 10% risk of mo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. all indoor newborn babies with HIE II and III
2. who have not received therapeutic hypothermia
Exclusion Criteria:
1. grade I HIE
2. Babies on TH
3. babies whose parents do not give consent for inclusion in study
4. babies with major congential malformations -
Contacts
arshad Khushdil
03463300030
CONTACT